This proposal is a continuation of an epidemiologic study of HIV among intravenous drug users (IVDUs) . This study would extend to 8 years the follow-up of a cohort of 765 IVDUs to continue the investigation of 3 important epidemiologic questions (AIM 1) and to initiate the study of health services utilization and medical charges incurred by HIV negative & HIV positive IVDUs (AIMS 2-5):
AIM 1 a: Estimate the change in incidence of the presence of antibodies to HIV among IVDUs who initially screen negative;
AIM 1 b: Estimate mortality rates for seropositive and seronegative IVDUs and ascertain cause of death;
AIM 1 c: Conduct survival analyses to estimate relative survival and determine prognostic factors that relate to survival and death.
AIM 2 : Determine the use of all types of medical care services by seronegative and seropositive IVDUs.
AIM 3 : Determine the charges for all types of medical care services utilized by seronegative and seropositive IVDUs.
AIM 4 : Determine the status and type of insurance coverage of cohort members, the patterns of change in coverage over time, the predictors of these changes, and the association between insurance coverage and the receipt of care.
AIM 5 : Describe factors that affect patterns of health care utilization. To accomplish Aims 1a-c, the cohort will be followed 4 additional years at 6 month intervals. To accomplish Aims 2-5, a """"""""nested"""""""" sample of the cohort will be supplemented with a sample of HIV positive IVDUs from an AIDS risk reduction program to create a pooled, stratified sample of 100 seronegative and 200 seropositive (100 asymptomatic, 100 symptomatic) IVDUs who will be followed at 6 month intervals for 4 years. To accomplish Aim 5, an ethnography of health services utilization will study 20 HIV-positive and 20 HIV negative IVDUs.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Research Project (R01)
Project #
Application #
Study Section
Sociobehavioral Subcommittee (DAAR)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Miami School of Medicine
Organized Research Units
United States
Zip Code
Shah, S M; Shapshak, P; Rivers, J E et al. (1996) Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. J Acquir Immune Defic Syndr Hum Retrovirol 11:301-6
McCoy, C B; Shapshak, P; Metsch, L R et al. (1995) HIV-1 prevention: interdisciplinary studies on the efficacy of bleach and development of prevention protocols. Arch Immunol Ther Exp (Warsz) 43:1-9
Chitwood, D D; Griffin, D K; Comerford, M et al. (1995) Risk factors for HIV-1 seroconversion among injection drug users: a case-control study. Am J Public Health 85:1538-42
McElrath, K; Chitwood, D D; Griffin, D K et al. (1994) The consistency of self-reported HIV risk behavior among injection drug users. Am J Public Health 84:1965-70
Shapshak, P; McCoy, C B; Shah, S M et al. (1994) Preliminary laboratory studies of inactivation of HIV-1 in needles and syringes containing infected blood using undiluted household bleach. J Acquir Immune Defic Syndr 7:754-9
McCoy, C B; Rivers, J E; McCoy, H V et al. (1994) Compliance to bleach disinfection protocols among injecting drug users in Miami. J Acquir Immune Defic Syndr 7:773-6
Shapshak, P; McCoy, C B; Rivers, J E et al. (1993) Inactivation of human immunodeficiency virus-1 at short time intervals using undiluted bleach. J Acquir Immune Defic Syndr 6:218-9
Chitwood, D D; Page, J B; Comerford, M et al. (1991) The donation and sale of blood by intravenous drug users. Am J Public Health 81:631-3
Chitwood, D D; McCoy, C B; Inciardi, J A et al. (1990) HIV seropositivity of needles from shooting galleries in south Florida. Am J Public Health 80:150-2